NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Epigenetic and genetic regulation of arsenic methylation and arsenic-relatedcardiovascular disease risk
Epigenetic and genetic regulation of arsenic methylation and arsenic-relatedcardiovascular disease risk is a funding opportunity from NEW YORK UNIVERSITY SCHOOL OF MEDICINE, up to 248999, closing May 31, 2029.
May 31, 2029
(1035d left)Overview
SUMMARY In the United States, Native American communities face the greatest burden of chronic diseases among all ethnic groups and high rates of cardiovascular disease (CVD) incidence and mortality. Elevated disease risk may be in part attributed to arsenic in drinking water, which is a key environmental risk factor…